Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes.

Trial Profile

Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs Gimatecan (Primary)
  • Indications Myelodysplastic syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Jun 2014 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center.
    • 07 Jun 2014 Status changed from discontinued to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
    • 03 Jun 2014 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top